Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection

Journal of Reproductive Immunology

Volumn 88, Issue 2, 2011, Pages 195-203

  Olesen, Rikke ^a,b   Wahl, Angela ^a   Denton, Paul W ^a   Victor Garcia, J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Female reproductive tract; Human immunodeficiency virus; Humanized BLT mice; Pre exposure prophylaxis; Vaginal transmission

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; MICROBICIDE; TENOFOVIR DISOPROXIL;

ANIMAL EXPERIMENT; B LYMPHOCYTE; CELL DIFFERENTIATION; DISEASE PREDISPOSITION; FEMALE GENITAL SYSTEM; FETUS LIVER; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INFECTION PREVENTION; LYMPHOCYTE DEPLETION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; T LYMPHOCYTE; THYMUS; UTERINE CERVIX; UTERINE ENDOCERVIX; UTERUS; VAGINA; VIRUS TRANSMISSION;

AIDS VACCINES; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HIV-1; HUMANS; INFECTION CONTROL; MICE; MICE, INBRED STRAINS; PREGNANCY; VAGINA;

EID: 79952704002     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.11.005     Document Type: Review

References (63)

1. Abdool Karim Q., Abdool Karim S.S., Frohlich J.A., Grobler A.C., Baxter C., Mansoor L.E., et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168-1174.
2. Arrighi J.F., Pion M., Garcia E., Escola J.M., Van Kooyk Y., Geijtenbeek T.B., et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 2004, 200:1279-1288.
3. Asin S.N., Eszterhas S.K., Rollenhagen C., Heimberg A.M., Howell A.L. HIV type 1 infection in women: increased transcription of HIV type 1 in ectocervical tissue explants. J. Infect. Dis. 2009, 200:965-972.
4. Bobardt M.D., Chatterji U., Selvarajah S., Van der Schueren B., David G., Kahn B., et al. Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J. Virol. 2007, 81:395-405.
5. Brainard D.M., Seung E., Frahm N., Cariappa A., Bailey C.C., Hart W.K., et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J. Virol. 2009, 83:7305-7321.
6. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., et al. CD4+T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004, 200:749-759.
7. De Clercq E. The acyclic nucleoside phosphonates from inception to clinical use: historical perspective. Antiviral Res. 2007, 75:1-13.
8. Denton P.W., Garcia J.V. Novel humanized murine models for HIV research. Curr. HIV/AIDS Rep. 2009, 6:13-19.
9. Denton P.W., Estes J.D., Sun Z., Othieno F.A., Wei B.L., Wege A.K., et al. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 2008, 5:e16.
10. Denton P.W., Krisko J.F., Powell D.A., Mathias M., Kwak Y.T., Martinez-Torres F., et al. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One 2010, 5:e8829.
11. Derdelinckx I., Wainberg M.A., Lange J.M., Hill A., Halima Y., Boucher C.A. Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection. PLoS Med. 2006, 3:e454.
12. Garcia-Lerma J.G., Paxton L., Kilmarx P.H., Heneine W. Oral pre-exposure prophylaxis for HIV prevention. Trends Pharmacol. Sci. 2010, 31:74-81.
13. Geijtenbeek T.B., Kwon D.S., Torensma R., Van Vliet S.J., Van Duijnhoven G.C., Middel J., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
14. Givan A.L., White H.D., Stern J.E., Colby E., Gosselin E.J., Guyre P.M., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am. J. Reprod. Immunol. 1997, 38:350-359.
15. Gray R.H., Wawer M.J., Brookmeyer R., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357:1149-1153.
16. Greenhead P., Hayes P., Watts P.S., Laing K.G., Griffin G.E., Shattock R.J. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 2000, 74:5577-5586.
17. Greiner D.L., Hesselton R.A., Shultz L.D. SCID mouse models of human stem cell engraftment. Stem Cells 1998, 16:166-177.
18. Gupta P., Collins K.B., Ratner D., Watkins S., Naus G.J., Landers D.V., et al. Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 2002, 76:9868-9876.
19. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464:217-223.
20. Harouse J.M., Gettie A., Tan R.C., Blanchard J., Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999, 284:816-819.
21. Hladik F., Sakchalathorn P., Ballweber L., Lentz G., Fialkow M., Eschenbach D., et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007, 26:257-270.
22. Howell A.L., Edkins R.D., Rier S.E., Yeaman G.R., Stern J.E., Fanger M.W., et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J. Virol. 1997, 71:3498-3506.
23. Hussain L.A., Kelly C.G., Fellowes R., Hecht E.M., Wilson J., Chapman M., et al. Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clin. Exp. Immunol. 1992, 90:530-538.
24. Johansson E.L., Rudin A., Wassen L., Holmgren J. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999, 96:272-277.
25. Kamat B.R., Isaacson P.G. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am. J. Pathol. 1987, 127:66-73.
26. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7552-7557.
27. Keele B.F., LI H., Learn G.H., Hraber P., Giorgi E.E., Grayson T., et al. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J. Exp. Med. 2009, 206:1117-1134.
28. Kell P.D., Barton S.E., Edmonds D.K., Boag F.C. HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser syndrome. J. R. Soc. Med. 1992, 85:706-707.
29. Lan P., Tonomura N., Shimizu A., Wang S., Yang Y.G. Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 2006, 108:487-492.
30. Leppi T.J. A study of the uterine cervix of the mouse. Anat. Rec. 1964, 150:51-65.
31. Li Q., Estes J.D., Schlievert P.M., Duan L., Brosnahan A.J., Southern P.J., et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009, 458:1034-1038.
32. Maher D., Wu X., Schacker T., Horbul J., Southern P. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11504-11509.
33. Mcdonald D., Wu L., Bohks S.M., Kewalramani V.N., Unutmaz D., Hope T.J. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003, 300:1295-1297.
34. Mehandru S., Poles M.A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 2004, 200:761-770.
35. Melkus M.W., Estes J.D., Padgett-Thomas A., Gatlin J., Denton P.W., Othieno F.A., et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006, 12:1316-1322.
36. Mermin J.H., Holodniy M., Katzenstein D.A., Merigan T.C. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J. Infect. Dis. 1991, 164:769-772.
37. Miller C.J., Hu J. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. J. Infect Dis. 1999, 179(Suppl. 3):S413-417.
38. Miller C.J., Alexander N.J., Vogel P., Anderson J., Marx P.A. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 1992, 21:64-68.
39. Miller C.J., Li Q., Abel K., Kim E.Y., Ma Z.M., Wietgrefe S., et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 2005, 79:9217-9227.
40. Nazli A., Chan O., Dobson-Belaire W.N., Ouellet M., Tremblay M.J., Gray-Owen S.D., et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010, 6:e1000852.
41. Norvell M.K., Benrubi G.I., Thompson R.J. Investigation of microtrauma after sexual intercourse. J. Reprod. Med. 1984, 29:269-271.
42. Padian N.S., Mccoy S.I., Balkus J.E., Wasserheit J.N. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010, 24:621-635.
43. Powers K.A., Poole C., Pettifor A.E., Cohen M.S. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect. Dis. 2008, 8:553-563.
44. Pudney J., Anderson D. Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. Am. J. Pathol. 1991, 139:149-160.
45. Pudney J., Quayle A.J., Anderson D.J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 2005, 73:1253-1263.
46. Quinn T.C., Wawer M.J., Sewankambo N., Serwadda D., Li C., Wabwire-Mangen F., et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 2000, 342:921-929.
47. Rajesh D., Zhou Y., Jankowska-Gan E., Roenneburg D.A., Dart M.L., Torrealba J., et al. Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice. Hum. Immunol. 2010, 71:551-559.
48. Rohan L.C., Moncla B.J., Kunjara Na Ayudhya R.P., Cost M., Huang Y., Gai F., et al. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One 2010, 5:e9310.
49. Saba E., Grivel J.C., Vanpouille C., Brichacek B., Fitzgerald W., Margolis L., et al. HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model. Mucosal Immunol. 2010, 3:280-290.
50. Shultz L.D., Lyons B.L., Burzenski L.M., Gott B., Chen X., Chaleff S., et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 2005, 174:6477-6489.
51. Sun Z., Denton P.W., Estes J.D., Othieno F.A., Wei B.L., Wege A.K., et al. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 2007, 204:705-714.
52. Supervie V., Garcia-Lerma J.G., Heneine W., Blower S. HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12381-12386.
53. Uberla K. Efficacy of AIDS vaccine strategies in nonhuman primates. Med. Microbiol. Immunol. 2005, 194:201-206.
54. UNAIDS, 2006. 2006 Report on the global AIDS epidemic [online]. Available: [accessed September 20, 2010]. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2006/default.asp.
55. UNAIDS, 2009. AIDS Epidemic Update: November 2009 [online]. Available: [accessed]. http://www.data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf.
56. Van Rompay K.K. Evaluation of antiretrovirals in animal models of HIV infection. Antiviral Res. 2010, 85:159-175.
57. Veazey R.S. Microbicide safety/efficacy studies in animals: macaques and small animal models. Curr. Opin. HIV AIDS 2008, 3:567-573.
58. Veazey R.S., Tham I.C., Mansfield K.G., Demaria M., Forand A.E., Shvetz D.E., et al. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 2000, 74:57-64.
59. Vernazza P.L., Eron J.J., Cohen M.S., Van Der Horst C.M., Troiani L., Fiscus S.A. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994, 8:1325-1329.
60. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., LI X., Laeyendecker O., et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 2005, 191:1403-1409.
61. Yeaman G.R., Guyre P.M., Fanger M.W., Collins J.E., White H.D., Rathbun W., et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J. Leukoc. Biol. 1997, 61:427-435.
62. Zhang Z., Schuler T., Zupancic M., Wietgrefe S., Staskus K.A., Reimann K.A., et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999, 286:1353-1357.
63. Zhang Z.Q., Wietgrefe S.W., Li Q., Shore M.D., Duan L., Reilly C., et al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:5640-5645.